Mackenzie Financial’s Inspire Medical Systems INSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$471K Buy
+10,551
New +$500K ﹤0.01% 1336
2023
Q2
Sell
-1,770
Closed -$414K 1572
2023
Q1
$414K Buy
+1,770
New +$447K ﹤0.01% 1075
2022
Q3
Sell
-1,859
Closed -$340K 1482
2022
Q2
$340K Buy
1,859
+361
+24% +$72K ﹤0.01% 1048
2022
Q1
$385K Sell
1,498
-85
-5% -$19.4K ﹤0.01% 1043
2021
Q4
$364K Sell
1,583
-258
-14% -$63K ﹤0.01% 1076
2021
Q3
$429K Buy
1,841
+627
+52% +$131K ﹤0.01% 1019
2021
Q2
$235K Buy
+1,214
New +$241K ﹤0.01% 1125

Other funds holding INSP

Mackenzie Financial's INSP Position: Q2 2026 in Review

Mackenzie Financial opened a new position in Inspire Medical Systems (INSP) in Q2 2026: 10,551 shares worth $471K. The stake represents ﹤0.01% of the portfolio and ranks #1336 among its holdings. This is a return to the name: Mackenzie Financial previously reported a position in INSP as recently as Q1 2023.

Mackenzie Financial first reported a position in INSP in Q2 2021 and has held it in 7 quarters since. 276 funds tracked by Wall St. Rank hold INSP as of Q2 2026.

  • Mackenzie Financial held 10,551 shares of Inspire Medical Systems worth $471K as of Q2 2026.
  • Inspire Medical Systems was a new Mackenzie Financial position in Q2 2026.
  • Inspire Medical Systems made up ﹤0.01% of Mackenzie Financial's portfolio in Q2 2026, its #1336 holding.
  • Mackenzie Financial first reported a position in Inspire Medical Systems in Q2 2021 and has held it in 7 quarters since.
  • 276 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q2 2026.

Based on Mackenzie Financial's 13F filing for Q2 2026, filed 13 Aug 2026.